|
Dr. Porter is Director General and CEO of the McGill University Health Centre (MUHC) in Montréal, Canada, one of the most comprehensive academic health centers in North America. From 1999 to 2004, Dr. Porter held the position of CEO of the Detroit Medical Center, a US$1.6 billion health system in one of the United States’ largest urban areas. In addition, Dr. Porter is on the Editorial Board of 13 scientific journals and has to his credit numerous scholarly works in peer-reviewed journals, chapters in books and in proceedings of conferences. Dr. Porter is, amongst others, a member of the Board of Directors and the Audit Committee of the Munder Funds, as well as a board member of Adherex, a publicly traded biotechnology company. Dr. Porter’s extensive international health background includes medical practice in radiation oncology, business and academic leadership positions in Canada, Europe, Africa and the United States. Each of the Company’s directors holds office until the next meeting of shareholders or until his or her successor is duly elected, unless prior thereto the director resigns or the director’s office becomes vacant by reason of death or other cause. | 